| 000 | 01406 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516080202.0 | ||
| 264 | 0 | _c20120604 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1875-533X | ||
| 024 | 7 |
_a10.2174/092986712803414240 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTello-Montoliu, A | |
| 245 | 0 | 0 |
_aNew perspectives in antiplatelet therapy. _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry _c2012 |
||
| 300 |
_a406-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPurinergic P2 Receptor Antagonists _xchemistry |
| 650 | 0 | 4 |
_aReceptor, PAR-1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Thromboxane _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 700 | 1 | _aJover, E | |
| 700 | 1 | _aRivera, J | |
| 700 | 1 | _aValdés, M | |
| 700 | 1 | _aAngiolillo, D J | |
| 700 | 1 | _aMarín, F | |
| 773 | 0 |
_tCurrent medicinal chemistry _gvol. 19 _gno. 3 _gp. 406-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/092986712803414240 _zAvailable from publisher's website |
| 999 |
_c21546336 _d21546336 |
||